Elacestrant, a selective estrogen receptor degrader, demonstrated significant improvements in progression-free survival (PFS) ...
Global Metastatic Colorectal Cancer Market to Record Stellar Growth with Advancements in Treatments and Rise in Healthcare InfrastructuresRockville, MD, Nov. 20, 2024 (GLOBE NEWSWIRE) -- According to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback